Login

Kathleen Skarvan, CEO, Electromed Inc 00:00:00

Share On Facebook Share On Twitter

Electromed, Inc ELMD CEO Kathleen Skarvan on 2020 Results

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Atal's Strong Sales Outlook and Optimistic 2024 Projections Amidst Share Price Dip|President, Atal SA
00:10:00
In-Depth Insights with Paul Singer: A Conversation on Principled Entrepreneurship at the Napa Institute 2020 Conference with Princeton's Robert P. George
00:10:00
Advancing Space Communication: Optical Laser Technology in Next-Generation Satellite Fleets |Bulent Altan , CEO , Mynaric AG.
00:10:00
Marcin Kuśmierz on Shoper SA’s Performance and Outlook Amid Rising Costs and Market Shifts | Marcin Kuśmierz, CEO , Shoper SA.
00:10:00
Apella Wealth offers financial planning services, highlighted in an explainer video.|Patrick A. Sweeny is a founding partner of Apella Capital.
00:10:00
CEO and Founder of Aritzia Shares His Journey with Bill Good | Brian Hill, CEO, Aritzia.
00:10:00
Leading Innovation in Technology: Enrique Lores on The David Rubenstein Show
00:10:00
An Introduction to JPMorgan American Investment Trust | The Association of Investment Companies
00:10:00
Insights from Dale: Growth and Quality at the One-to-One Mining Conference
00:10:00
Grant Moore Discusses Strategic Importance and Advancements at Lockerby East Nickel Project
00:10:00
"Dynamic Asset Allocation for Drawdown Protection: Des Lawrence of State Street Global Advisors on Leveraging the Market Regime Indicator for Strategic Investments"
00:00:00
Advanced Oncotherapy PLC on its proton beam therapy system - Dr Johnathan Farr , chief clinical officer at Advanced Oncotherapy

© 2026 Nehu